Bicycle Therapeutics plc (BCYC)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 863.00M |
| Enterprise value | 381.53M |
| Trailing P/E | 1.84k |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 29.99 |
| Price/book (mrq) | 2.33 |
| Enterprise value/revenue | 14.14 |
| Enterprise value/EBITDA | -2.25 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.89 |
| 52-week change 3 | 9.97% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 28.91 |
| 52-week low 3 | 12.54 |
| 50-day moving average 3 | 23.90 |
| 200-day moving average 3 | 20.32 |
Share statistics
| Avg vol (3-month) 3 | 395.49k |
| Avg vol (10-day) 3 | 370.92k |
| Shares outstanding 5 | 37.97M |
| Implied shares outstanding 6 | 36.71M |
| Float 8 | N/A |
| % held by insiders 1 | 1.64% |
| % held by institutions 1 | 105.27% |
| Shares short (15 Apr 2024) 4 | 2.96M |
| Short ratio (15 Apr 2024) 4 | 7.04 |
| Short % of float (15 Apr 2024) 4 | 8.58% |
| Short % of shares outstanding (15 Apr 2024) 4 | 7.80% |
| Shares short (prior month 15 Mar 2024) 4 | 2.56M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,017.35% |
Management effectiveness
| Return on assets (ttm) | -23.60% |
| Return on equity (ttm) | -56.31% |
Income statement
| Revenue (ttm) | 26.98M |
| Revenue per share (ttm) | 0.76 |
| Quarterly revenue growth (yoy) | 67.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -183.4M |
| Net income avi to common (ttm) | -180.66M |
| Diluted EPS (ttm) | -5.08 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 526.42M |
| Total cash per share (mrq) | 12.36 |
| Total debt (mrq) | 44.96M |
| Total debt/equity (mrq) | 12.12% |
| Current ratio (mrq) | 8.08 |
| Book value per share (mrq) | 8.74 |
Cash flow statement
| Operating cash flow (ttm) | -60.63M |
| Levered free cash flow (ttm) | -75.43M |
© 2024 Yahoo. All rights reserved.